首页 > 最新文献

Revista Espanola De Medicina Nuclear E Imagen Molecular最新文献

英文 中文
Estado del arte y perspectivas futuras de nuevos radionúclidos en Medicina Nuclear. Parte I 核医学新放射性核素的现状和未来展望。第一部分
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-01-01 DOI: 10.1016/j.remn.2024.500082
J.J. Rosales , M.L. Domínguez , L. Sancho , E. Prieto , M. de Arcocha , I. Torres , A. Roteta , R. Ramos , G. Quincoces , en nombre del Grupo de Oncología de la SEMNIM
This continuing education analyzes recent advances in Nuclear Medicine focused on the development of new radiopharmaceuticals that improve both the diagnosis and treatment of complex diseases. The focus is on teragnosis, which combines diagnosis and treatment by means of pairs of radiopharmaceuticals directed to the same molecular target, which allows the personalization of treatments.
This first part specifically reviews the teragnostic pairs copper-64/copper-67, lead-212/lead-203 and scandium-44/scandium-47, highlighting their physical characteristics, methods of production and potential clinical applications.
Despite the challenges in their production, their versatility and effectiveness are driving their clinical application in oncology and other diseases. The text also addresses the development of new radiopharmaceuticals and their impact on precision medicine, pointing out future directions and opportunities for research in this field.
这一继续教育分析了核医学的最新进展,重点是开发新的放射性药物,改善复杂疾病的诊断和治疗。重点是畸形诊断,它将诊断和治疗结合起来,通过针对同一分子靶点的成对放射性药物,从而实现治疗的个性化。本文第一部分详细介绍了铜64/铜67、铅212/铅203和钪44/钪47这三种诊断配对,重点介绍了它们的物理特性、制备方法和潜在的临床应用。尽管在生产中存在挑战,但其多功能性和有效性正在推动其在肿瘤和其他疾病中的临床应用。本文还讨论了新的放射性药物的发展及其对精密医学的影响,指出了该领域研究的未来方向和机会。
{"title":"Estado del arte y perspectivas futuras de nuevos radionúclidos en Medicina Nuclear. Parte I","authors":"J.J. Rosales ,&nbsp;M.L. Domínguez ,&nbsp;L. Sancho ,&nbsp;E. Prieto ,&nbsp;M. de Arcocha ,&nbsp;I. Torres ,&nbsp;A. Roteta ,&nbsp;R. Ramos ,&nbsp;G. Quincoces ,&nbsp;en nombre del Grupo de Oncología de la SEMNIM","doi":"10.1016/j.remn.2024.500082","DOIUrl":"10.1016/j.remn.2024.500082","url":null,"abstract":"<div><div>This continuing education analyzes recent advances in Nuclear Medicine focused on the development of new radiopharmaceuticals that improve both the diagnosis and treatment of complex diseases. The focus is on teragnosis, which combines diagnosis and treatment by means of pairs of radiopharmaceuticals directed to the same molecular target, which allows the personalization of treatments.</div><div>This first part specifically reviews the teragnostic pairs copper-64/copper-67, lead-212/lead-203 and scandium-44/scandium-47, highlighting their physical characteristics, methods of production and potential clinical applications.</div><div>Despite the challenges in their production, their versatility and effectiveness are driving their clinical application in oncology and other diseases. The text also addresses the development of new radiopharmaceuticals and their impact on precision medicine, pointing out future directions and opportunities for research in this field.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500082"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143096747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluación de la fiabilidad y legibilidad de las respuestas de los chatbots como recurso de información al paciente para las exploraciones PET-TC más comunes 评估聊天机器人作为最常见的PET-TC扫描的患者信息来源的响应的可靠性和可读性
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-01-01 DOI: 10.1016/j.remn.2024.500065
N. Aydinbelge-Dizdar , K. Dizdar

Purpose

This study aimed to evaluate the reliability and readability of responses generated by two popular AI-chatbots, ‘ChatGPT-4.0’ and ‘Google Gemini’, to potential patient questions about PET/CT scans.

Materials and methods

Thirty potential questions for each of [18F]FDG and [68Ga]Ga-DOTA-SSTR PET/CT, and twenty-nine potential questions for [68Ga]Ga-PSMA PET/CT were asked separately to ChatGPT-4 and Gemini in May 2024. The responses were evaluated for reliability and readability using the modified DISCERN (mDISCERN) scale, Flesch Reading Ease (FRE), Gunning Fog Index (GFI), and Flesch-Kincaid Reading Grade Level (FKRGL). The inter-rater reliability of mDISCERN scores provided by three raters (ChatGPT-4, Gemini, and a nuclear medicine physician) for the responses was assessed.

Results

The median [min-max] mDISCERN scores reviewed by the physician for responses about FDG, PSMA and DOTA PET/CT scans were 3.5 [2-4], 3 [3-4], 3 [3-4] for ChatGPT-4 and 4 [2-5], 4 [2-5], 3.5 [3-5] for Gemini, respectively. The mDISCERN scores assessed using ChatGPT-4 for answers about FDG, PSMA, and DOTA-SSTR PET/CT scans were 3.5 [3-5], 3 [3-4], 3 [2-3] for ChatGPT-4, and 4 [3-5], 4 [3-5], 4 [3-5] for Gemini, respectively. The mDISCERN scores evaluated using Gemini for responses FDG, PSMA, and DOTA-SSTR PET/CTs were 3 [2-4], 2 [2-4], 3 [2-4] for ChatGPT-4, and 3 [2-5], 3 [1-5], 3 [2-5] for Gemini, respectively. The inter-rater reliability correlation coefficient of mDISCERN scores for ChatGPT-4 responses about FDG, PSMA, and DOTA-SSTR PET/CT scans were 0.629 (95% CI= 0,32-0,812), 0.707 (95% CI = 0.458-0.853) and 0.738 (95% CI = 0.519-0.866), respectively (p< 0.001). The correlation coefficient of mDISCERN scores for Gemini responses about FDG, PSMA, and DOTA-SSTR PET/CT scans were 0.824 (95% CI = 0.677-0.910), 0.881 (95% CI = 0.78-0.94) and 0.847 (95% CI = 0.719-0.922), respectively (p< 0.001). The mDISCERN scores assessed by ChatGPT-4, Gemini, and the physician showed that the chatbots’ responses about all PET/CT scans had moderate to good statistical agreement according to the inter-rater reliability correlation coefficient (p< 0,001). There was a statistically significant difference in all readability scores (FKRGL, GFI, and FRE) of ChatGPT-4 and Gemini responses about PET/CT scans (p< 0,001). Gemini responses were shorter and had better readability scores than ChatGPT-4 responses.

Conclusion

There was an acceptable level of agreement between raters for the mDISCERN score, indicating agreement with the overall reliability of the responses. However, the information provided by AI-chatbots cannot be easily read by the public.
本研究旨在评估两种流行的人工智能聊天机器人“ChatGPT-4.0”和“谷歌Gemini”对患者关于PET/CT扫描的潜在问题所产生的回答的可靠性和可读性。材料与方法于2024年5月分别向ChatGPT-4和Gemini询问[18F]FDG和[68Ga]Ga-DOTA-SSTR PET/CT各30个潜在问题和[68Ga]Ga-PSMA PET/CT 29个潜在问题。采用改进的DISCERN (mDISCERN)量表、Flesch Reading Ease (FRE)、Gunning Fog Index (GFI)和Flesch- kincaid Reading Grade Level (FKRGL)评估问卷的可靠性和可读性。评估了三位评价者(ChatGPT-4、Gemini和一名核医学医师)提供的mDISCERN评分的评分间信度。结果医生对FDG、PSMA和DOTA PET/CT扫描反应的mDISCERN评分中位数[最小-最大]分别为ChatGPT-4的3.5[2-4]、3[3-4]、3 [3-4],Gemini的4[2-5]、4[2-5]、3.5[3-5]。使用ChatGPT-4对FDG、PSMA和DOTA-SSTR PET/CT扫描的答案进行mDISCERN评分,ChatGPT-4的得分分别为3.5[3-5]、3[3-4]、3 [2-3],Gemini的得分分别为4[3-5]、4[3-5]、4[3-5]。使用Gemini评估FDG、PSMA和DOTA-SSTR PET/ ct的mDISCERN得分分别为ChatGPT-4的3[2-4]、2[2-4]、3 [2-4],Gemini的3[2-5]、3[1-5]、3[2-5]。ChatGPT-4对FDG、PSMA和DOTA-SSTR PET/CT扫描反应的mDISCERN评分的评分间信度相关系数分别为0.629 (95% CI= 0,32-0,812)、0.707 (95% CI= 0.458-0.853)和0.738 (95% CI= 0.519-0.866) (p<;0.001)。mDISCERN评分与双子座FDG、PSMA和DOTA-SSTR PET/CT扫描反应的相关系数分别为0.824 (95% CI = 0.677-0.910)、0.881 (95% CI = 0.78-0.94)和0.847 (95% CI = 0.719-0.922) (p<;0.001)。由ChatGPT-4、Gemini和医生评估的mDISCERN分数表明,聊天机器人对所有PET/CT扫描的反应具有中等到良好的统计一致性,根据评分间信度相关系数(p<;0001)。ChatGPT-4和Gemini对PET/CT扫描的所有可读性评分(FKRGL、GFI和FRE)存在统计学上的显著差异(p<;0001)。双子座的回答比ChatGPT-4的回答更短,可读性得分更高。结论评定者对mDISCERN评分的一致性在一个可接受的水平上,表明其总体可靠性是一致的。然而,人工智能聊天机器人提供的信息并不容易被公众阅读。
{"title":"Evaluación de la fiabilidad y legibilidad de las respuestas de los chatbots como recurso de información al paciente para las exploraciones PET-TC más comunes","authors":"N. Aydinbelge-Dizdar ,&nbsp;K. Dizdar","doi":"10.1016/j.remn.2024.500065","DOIUrl":"10.1016/j.remn.2024.500065","url":null,"abstract":"<div><h3>Purpose</h3><div>This study aimed to evaluate the reliability and readability of responses generated by two popular AI-chatbots, ‘ChatGPT-4.0’ and ‘Google Gemini’, to potential patient questions about PET/CT scans.</div></div><div><h3>Materials and methods</h3><div>Thirty potential questions for each of [<sup>18</sup>F]FDG and [<sup>68</sup>Ga]Ga-DOTA-SSTR PET/CT, and twenty-nine potential questions for [<sup>68</sup>Ga]Ga-PSMA PET/CT were asked separately to ChatGPT-4 and Gemini in May 2024. The responses were evaluated for reliability and readability using the modified DISCERN (mDISCERN) scale, Flesch Reading Ease (FRE), Gunning Fog Index (GFI), and Flesch-Kincaid Reading Grade Level (FKRGL). The inter-rater reliability of mDISCERN scores provided by three raters (ChatGPT-4, Gemini, and a nuclear medicine physician) for the responses was assessed.</div></div><div><h3>Results</h3><div>The median [min-max] mDISCERN scores reviewed by the physician for responses about FDG, PSMA and DOTA PET/CT scans were 3.5 [2-4], 3 [3-4], 3 [3-4] for ChatGPT-4 and 4 [2-5], 4 [2-5], 3.5 [3-5] for Gemini, respectively. The mDISCERN scores assessed using ChatGPT-4 for answers about FDG, PSMA, and DOTA-SSTR PET/CT scans were 3.5 [3-5], 3 [3-4], 3 [2-3] for ChatGPT-4, and 4 [3-5], 4 [3-5], 4 [3-5] for Gemini, respectively. The mDISCERN scores evaluated using Gemini for responses FDG, PSMA, and DOTA-SSTR PET/CTs were 3 [2-4], 2 [2-4], 3 [2-4] for ChatGPT-4, and 3 [2-5], 3 [1-5], 3 [2-5] for Gemini, respectively. The inter-rater reliability correlation coefficient of mDISCERN scores for ChatGPT-4 responses about FDG, PSMA, and DOTA-SSTR PET/CT scans were 0.629 (95% CI= 0,32-0,812), 0.707 (95% CI<!--> <!-->=<!--> <!-->0.458-0.853) and 0.738 (95% CI<!--> <!-->=<!--> <!-->0.519-0.866), respectively (p&lt;<!--> <!-->0.001). The correlation coefficient of mDISCERN scores for Gemini responses about FDG, PSMA, and DOTA-SSTR PET/CT scans were 0.824 (95% CI<!--> <!-->=<!--> <!-->0.677-0.910), 0.881 (95% CI<!--> <!-->=<!--> <!-->0.78-0.94) and 0.847 (95% CI<!--> <!-->=<!--> <!-->0.719-0.922), respectively (p&lt;<!--> <!-->0.001). The mDISCERN scores assessed by ChatGPT-4, Gemini, and the physician showed that the chatbots’ responses about all PET/CT scans had moderate to good statistical agreement according to the inter-rater reliability correlation coefficient (p&lt;<!--> <!-->0,001). There was a statistically significant difference in all readability scores (FKRGL, GFI, and FRE) of ChatGPT-4 and Gemini responses about PET/CT scans (p&lt;<!--> <!-->0,001). Gemini responses were shorter and had better readability scores than ChatGPT-4 responses.</div></div><div><h3>Conclusion</h3><div>There was an acceptable level of agreement between raters for the mDISCERN score, indicating agreement with the overall reliability of the responses. However, the information provided by AI-chatbots cannot be easily read by the public.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500065"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143096585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metástasis ganglionares mediastínicas de cáncer de próstata: mayor precisión diagnóstica de la PET/TC con 18F-DCFPyL frente a la 18F-colina 前列腺癌中期淋巴结转移:与18F-胆碱相比,使用18F-DCFPyL进行PET/ CT的诊断准确率更高
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-01-01 DOI: 10.1016/j.remn.2024.500063
R.M. Angulo Amorese, F.J. Pena Pardo, J.C. Rodríguez Gómez, N. Disotuar Ruiz, M.P. Talavera Rubio, V.M. Poblete García
{"title":"Metástasis ganglionares mediastínicas de cáncer de próstata: mayor precisión diagnóstica de la PET/TC con 18F-DCFPyL frente a la 18F-colina","authors":"R.M. Angulo Amorese,&nbsp;F.J. Pena Pardo,&nbsp;J.C. Rodríguez Gómez,&nbsp;N. Disotuar Ruiz,&nbsp;M.P. Talavera Rubio,&nbsp;V.M. Poblete García","doi":"10.1016/j.remn.2024.500063","DOIUrl":"10.1016/j.remn.2024.500063","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500063"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143095660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asociación de los hallazgos de la PET-TC y la VATS con la histología pleural en el estudio del derrame pleural PET-TC和VATS的发现与胸膜组织学在胸膜溢漏研究中的关联
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-01-01 DOI: 10.1016/j.remn.2024.500059
M. Simó , O. Persiva , L. Sánchez , J.B. Montoro , I. Sansano , A. Vázquez , F. Ascanio , C. Alemán

Introduction

Histological analysis of the pleura obtained by video-assisted thoracoscopic surgery (VATS) is the best diagnostic technique in the study of neoplastic pleural effusions. This study evaluates the relationship between positron emission tomography (PET)/computed tomography (CT) and VATS findings, the result of the first pleural biopsy, and the final diagnosis of malignancy or non-malignancy.

Methods

Prospective study of consecutive patients with pleural effusions undergoing PET/CT and VATS from October 2013 to December 2023. The following variables were recorded: PET/CT score (nodular pleural thickening, pleural nodules with standardized uptake value (SUV) > 7.5, lung mass or extra pleural malignancy, mammary lymph node with SUV > 4.5 and cardiomegaly); VATS data (drained volume, visceral and parietal pleural thickening, nodules or masses, septa, plaques, fluid appearance, trapped lung, and suspected diagnosis of the procedure), as well as the histological study of the first pleural biopsy (benign or malignant) and the final diagnosis of benign or malignant pleural effusion. A logistic regression study of the variables was performed.

Results

95.8% of the patients with PET/CT and pleuroscopy not suggestive of malignancy had non-malignant histological findings, while 93.2% of the patients with PET/CT and pleuroscopy suggestive of malignancy had malignant histological findings. PET/CT, pleuroscopy, and the result of the first pleural biopsy showed a significant association with the final diagnosis of pleural effusion.

Conclusions

There is a strong association between PET/CT findings, VATS and pleural histology.
通过电视胸腔镜手术(VATS)对胸膜进行组织学分析是研究肿瘤性胸腔积液的最佳诊断技术。本研究评估正电子发射断层扫描(PET)/计算机断层扫描(CT)与VATS结果、首次胸膜活检结果以及最终诊断恶性或非恶性之间的关系。方法前瞻性研究2013年10月至2023年12月连续接受PET/CT和VATS检查的胸腔积液患者。记录以下变量:PET/CT评分(结节性胸膜增厚,胸膜结节标准化摄取值(SUV) >;7.5、肺肿块或胸膜外恶性肿瘤、乳腺淋巴结合并SUV >;4.5和心脏肥大);VATS数据(排气量、内脏和胸膜壁层增厚、结节或肿块、间隔、斑块、液体外观、肺陷陷和手术的可疑诊断),以及第一次胸膜活检(良性或恶性)的组织学研究和良性或恶性胸膜积液的最终诊断。结果PET/CT及胸腔镜检查未提示恶性的患者组织学表现为非恶性的占95.8%,PET/CT及胸腔镜检查提示恶性的患者组织学表现为恶性的占93.2%。PET/CT、胸膜镜检查和第一次胸膜活检结果显示与最终诊断胸腔积液有显著相关性。结论PET/CT表现、VATS与胸膜组织学有很强的相关性。
{"title":"Asociación de los hallazgos de la PET-TC y la VATS con la histología pleural en el estudio del derrame pleural","authors":"M. Simó ,&nbsp;O. Persiva ,&nbsp;L. Sánchez ,&nbsp;J.B. Montoro ,&nbsp;I. Sansano ,&nbsp;A. Vázquez ,&nbsp;F. Ascanio ,&nbsp;C. Alemán","doi":"10.1016/j.remn.2024.500059","DOIUrl":"10.1016/j.remn.2024.500059","url":null,"abstract":"<div><h3>Introduction</h3><div>Histological analysis of the pleura obtained by video-assisted thoracoscopic surgery (VATS) is the best diagnostic technique in the study of neoplastic pleural effusions. This study evaluates the relationship between positron emission tomography (PET)/computed tomography (CT) and VATS findings, the result of the first pleural biopsy, and the final diagnosis of malignancy or non-malignancy.</div></div><div><h3>Methods</h3><div>Prospective study of consecutive patients with pleural effusions undergoing PET/CT and VATS from October 2013 to December 2023. The following variables were recorded: PET/CT score (nodular pleural thickening, pleural nodules with standardized uptake value (SUV) &gt;<!--> <!-->7.5, lung mass or extra pleural malignancy, mammary lymph node with SUV &gt;<!--> <!-->4.5 and cardiomegaly); VATS data (drained volume, visceral and parietal pleural thickening, nodules or masses, septa, plaques, fluid appearance, trapped lung, and suspected diagnosis of the procedure), as well as the histological study of the first pleural biopsy (benign or malignant) and the final diagnosis of benign or malignant pleural effusion. A logistic regression study of the variables was performed.</div></div><div><h3>Results</h3><div>95.8% of the patients with PET/CT and pleuroscopy not suggestive of malignancy had non-malignant histological findings, while 93.2% of the patients with PET/CT and pleuroscopy suggestive of malignancy had malignant histological findings. PET/CT, pleuroscopy, and the result of the first pleural biopsy showed a significant association with the final diagnosis of pleural effusion.</div></div><div><h3>Conclusions</h3><div>There is a strong association between PET/CT findings, VATS and pleural histology.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500059"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143096586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PET-TC [18F]F-Colina y PTH intraoperatoria en el tratamiento quirúrgico del hiperparatiroidismo primario sin localización preoperatoria PET-TC [18F]F-胆碱和PTH在无术前部位原发性甲状旁腺功能亢进的手术治疗中的应用
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-01-01 DOI: 10.1016/j.remn.2024.500066
F.G. García-García , N. Cassinello Fernández , J. Rodríguez Romera , R. Martí Fernández , M. Lapeña Rodríguez , R. Alfonso Ballester , R. Díaz Expósito , J. Ortega Serrano

Background and objectives

To assess the feasibility of performing selective parathyroidectomy without intraoperative parathyroid hormone (PTHio) determination when first-line preoperative localization tests (ultrasonography and [99mTc]Tc-MIBI) are negative and/or discordant, and second-line [18F]F-Colina PET-CT, is positive.

Materials and methods

Retrospective cohort study, including patients with negative or discordant ultrasound and MIBI scans and positive [18F]F-Colina PET-CT, who underwent selective parathyroidectomy between 2019 and 2022. Groups were compared based on PTHio determination. Study variables were: gender, mean age, biochemical cure assessed by PTH value (pg/mL) and corrected calcium by albumin (mg/dL) at 6 months post-surgery follow-up, and histopathological analysis.

Results

The final sample included 42 patients. At 6 months post-surgery, in the PTHio group (20 patients), PTH values were 64.50 pg/mL and calcium 9.30 pg/mL, with 19 adenomas and 1 hyperplasia found. In the non-PTHio group (22 patients), PTH values were 61 pg/mL and calcium 9.37 pg/mL, with 22 adenomas found. No statistically significant differences were found between both groups.

Conclusions

Based on the results obtained in our patient cohort, selective parathyroidectomy could be considered with negative or discordant first-line tests and positive [18F]F-Colina PET-CT, without intraoperative PTH determination.
背景与目的评价在一线术前定位检查(超声和[99mTc]Tc-MIBI)阴性和/或不一致,二线[18F]F-Colina PET-CT阳性的情况下,在不检测术中甲状旁腺激素(PTHio)的情况下进行选择性甲状旁腺切除术的可行性。材料与方法回顾性队列研究,纳入2019 - 2022年间行选择性甲状旁腺切除术的超声和MIBI扫描阴性或不一致、F-Colina PET-CT阳性[18F]的患者。各组间以PTHio测定值进行比较。研究变量为:性别、平均年龄、术后随访6个月以PTH值(pg/mL)评估生化治愈、白蛋白校正钙(mg/dL)评估生化治愈以及组织病理学分析。结果最终纳入42例患者。术后6个月,PTHio组(20例)PTH值64.50 pg/mL,钙9.30 pg/mL,腺瘤19例,增生1例。在非pthio组(22例)中,PTH值为61 pg/mL,钙为9.37 pg/mL, 22例发现腺瘤。两组间无统计学差异。结论根据我们患者队列的结果,如果一线检查阴性或不一致,F-Colina PET-CT阳性[18F],可以考虑选择性甲状旁腺切除术,术中不需要检测甲状旁腺激素。
{"title":"PET-TC [18F]F-Colina y PTH intraoperatoria en el tratamiento quirúrgico del hiperparatiroidismo primario sin localización preoperatoria","authors":"F.G. García-García ,&nbsp;N. Cassinello Fernández ,&nbsp;J. Rodríguez Romera ,&nbsp;R. Martí Fernández ,&nbsp;M. Lapeña Rodríguez ,&nbsp;R. Alfonso Ballester ,&nbsp;R. Díaz Expósito ,&nbsp;J. Ortega Serrano","doi":"10.1016/j.remn.2024.500066","DOIUrl":"10.1016/j.remn.2024.500066","url":null,"abstract":"<div><h3>Background and objectives</h3><div>To assess the feasibility of performing selective parathyroidectomy without intraoperative parathyroid hormone (PTHio) determination when first-line preoperative localization tests (ultrasonography and [<sup>99m</sup>Tc]Tc-MIBI) are negative and/or discordant, and second-line [<sup>18</sup>F]F-Colina PET-CT, is positive.</div></div><div><h3>Materials and methods</h3><div>Retrospective cohort study, including patients with negative or discordant ultrasound and MIBI scans and positive [<sup>18</sup>F]F-Colina PET-CT, who underwent selective parathyroidectomy between 2019 and 2022. Groups were compared based on PTHio determination. Study variables were: gender, mean age, biochemical cure assessed by PTH value (pg/mL) and corrected calcium by albumin (mg/dL) at 6 months post-surgery follow-up, and histopathological analysis.</div></div><div><h3>Results</h3><div>The final sample included 42 patients. At 6 months post-surgery, in the PTHio group (20 patients), PTH values were 64.50 pg/mL and calcium 9.30 pg/mL, with 19 adenomas and 1 hyperplasia found. In the non-PTHio group (22 patients), PTH values were 61 pg/mL and calcium 9.37 pg/mL, with 22 adenomas found. No statistically significant differences were found between both groups.</div></div><div><h3>Conclusions</h3><div>Based on the results obtained in our patient cohort, selective parathyroidectomy could be considered with negative or discordant first-line tests and positive [<sup>18</sup>F]F-Colina PET-CT, without intraoperative PTH determination.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500066"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143105218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
18F-FDG PET/TC en la estadificación, evaluación terapéutica y seguimiento de un sarcoma prostático 18F-FDG PET/TC在前列腺肉瘤的发展、治疗评价和随访中的作用
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-01-01 DOI: 10.1016/j.remn.2024.500039
I. Martínez-Rodríguez, F. Gómez-de la Fuente, A. Sánchez-Salmón, M. Pombo-López, A. Bota-Bota, R. Quirce
{"title":"18F-FDG PET/TC en la estadificación, evaluación terapéutica y seguimiento de un sarcoma prostático","authors":"I. Martínez-Rodríguez,&nbsp;F. Gómez-de la Fuente,&nbsp;A. Sánchez-Salmón,&nbsp;M. Pombo-López,&nbsp;A. Bota-Bota,&nbsp;R. Quirce","doi":"10.1016/j.remn.2024.500039","DOIUrl":"10.1016/j.remn.2024.500039","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500039"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143105219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remisión metabólica completa de neoplasia blástica generalizada de células dendríticas plasmocitoides tras tratamiento 治疗后全面性浆细胞树突状细胞增生完全代谢缓解
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-01-01 DOI: 10.1016/j.remn.2024.500040
N. Filizoglu , S. Ozguven
{"title":"Remisión metabólica completa de neoplasia blástica generalizada de células dendríticas plasmocitoides tras tratamiento","authors":"N. Filizoglu ,&nbsp;S. Ozguven","doi":"10.1016/j.remn.2024.500040","DOIUrl":"10.1016/j.remn.2024.500040","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500040"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143105220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uso de propranolol en 18F-FDG-PET/TC para el diagnóstico diferencial de grasa parda en una paciente con antecedente de adenocarcinoma de cérvix uterino 使用普萘洛尔18F-FDG-PET/TC对有宫颈癌腺癌病史的患者进行脂质鉴别诊断
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-01-01 DOI: 10.1016/j.remn.2024.500068
A. Garcia Garcia , A.P. Caresia Aróztegui , S. Martínez Román
{"title":"Uso de propranolol en 18F-FDG-PET/TC para el diagnóstico diferencial de grasa parda en una paciente con antecedente de adenocarcinoma de cérvix uterino","authors":"A. Garcia Garcia ,&nbsp;A.P. Caresia Aróztegui ,&nbsp;S. Martínez Román","doi":"10.1016/j.remn.2024.500068","DOIUrl":"10.1016/j.remn.2024.500068","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500068"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143095659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efecto antitumoral de la vertebroplastia en la metástasis vertebral basado en el análisis cuantitativo de la PET/TC con 18F-FDG 基于PET/ CT与18F-FDG定量分析的脊柱成形术对脊柱转移的抗肿瘤作用
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-01-01 DOI: 10.1016/j.remn.2024.500028
L. Bian , C. Yang , S.-w. Yin , C.-f. Ni
{"title":"Efecto antitumoral de la vertebroplastia en la metástasis vertebral basado en el análisis cuantitativo de la PET/TC con 18F-FDG","authors":"L. Bian ,&nbsp;C. Yang ,&nbsp;S.-w. Yin ,&nbsp;C.-f. Ni","doi":"10.1016/j.remn.2024.500028","DOIUrl":"10.1016/j.remn.2024.500028","url":null,"abstract":"","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500028"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143095661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gammagrafía peritoneal y SPECT/CT en el diagnóstico de fugas en pacientes en diálisis peritoneal 腹膜X射线照相和SPECT/CT在诊断腹膜透析患者漏液中的应用
IF 1.6 4区 医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-01-01 DOI: 10.1016/j.remn.2024.500067
D. Tercero Garrido , M.V. Guiote Moreno , C. Rodelo-Haad , P.I. Contreras Puertas , S. Soriano Cabrera , M.D. Albalá González

Objective

To assess the usefulness of peritoneal cavity scintigraphy and the contribution of SPECT/CT in patients on peritoneal dialysis with suspected leak.

Methodology

An observational case series study is carried out. It consists of a longitudinal, retrospective and descriptive study. 11 patients on peritoneal dialysis were studied and it was realiced a peritoneal cavity scintigraphy test and SPECT/CT to evaluate a peritoneal leak.

Results

In 54,5% of the patients, a positive study of peritoneal leak was obtained. The most frequent localitations were in the abdominal wall at the catheter entry level and the inguinal hernia. In the cases with sintomatology like pain and celullitis of the subcutaneous tract of the cateter the frequent of leak was 100%. There was a change in therapeutic management in patients with a positive study. There was not relevant changes in initial dialysis regimen in patients with a negative study. In this cases, except for one patient who required hemodialysis, all patients experienced clinical improvement.

Conclusions

Peritoneal scintigraphy and SPECT/CT study are non-invasive techniques that allow an adequate diagnosis and subsequent management of peritoneal leak.
目的探讨腹腔显像及SPECT/CT在腹膜透析疑似渗漏患者中的应用价值。方法采用观察性病例系列研究。它由纵向、回顾性和描述性研究组成。本文对11例腹膜透析患者进行了研究,采用腹腔显像检查和SPECT/CT评估腹膜渗漏。结果54.5%的患者腹膜漏检阳性。最常见的位置是在导管进入水平的腹壁和腹股沟疝。在有鼻窦病变如疼痛和皮下蜂窝组织炎的病例中,漏尿的发生率为100%。阳性研究患者的治疗管理发生了变化。阴性研究患者的初始透析方案无相关变化。在本病例中,除了一名患者需要血液透析外,所有患者的临床症状均有所改善。结论腹腔显像和SPECT/CT检查是非侵入性技术,可对腹膜渗漏进行充分的诊断和后续处理。
{"title":"Gammagrafía peritoneal y SPECT/CT en el diagnóstico de fugas en pacientes en diálisis peritoneal","authors":"D. Tercero Garrido ,&nbsp;M.V. Guiote Moreno ,&nbsp;C. Rodelo-Haad ,&nbsp;P.I. Contreras Puertas ,&nbsp;S. Soriano Cabrera ,&nbsp;M.D. Albalá González","doi":"10.1016/j.remn.2024.500067","DOIUrl":"10.1016/j.remn.2024.500067","url":null,"abstract":"<div><h3>Objective</h3><div>To assess the usefulness of peritoneal cavity scintigraphy and the contribution of SPECT/CT in patients on peritoneal dialysis with suspected leak.</div></div><div><h3>Methodology</h3><div>An observational case series study is carried out. It consists of a longitudinal, retrospective and descriptive study. 11 patients on peritoneal dialysis were studied and it was realiced a peritoneal cavity scintigraphy test and SPECT/CT to evaluate a peritoneal leak.</div></div><div><h3>Results</h3><div>In 54,5% of the patients, a positive study of peritoneal leak was obtained. The most frequent localitations were in the abdominal wall at the catheter entry level and the inguinal hernia. In the cases with sintomatology like pain and celullitis of the subcutaneous tract of the cateter the frequent of leak was 100%. There was a change in therapeutic management in patients with a positive study. There was not relevant changes in initial dialysis regimen in patients with a negative study. In this cases, except for one patient who required hemodialysis, all patients experienced clinical improvement.</div></div><div><h3>Conclusions</h3><div>Peritoneal scintigraphy and SPECT/CT study are non-invasive techniques that allow an adequate diagnosis and subsequent management of peritoneal leak.</div></div>","PeriodicalId":48986,"journal":{"name":"Revista Espanola De Medicina Nuclear E Imagen Molecular","volume":"44 1","pages":"Article 500067"},"PeriodicalIF":1.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143135593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista Espanola De Medicina Nuclear E Imagen Molecular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1